Transforming Lives

Through a new class of safe, durable cancer treatments.

In The News

    • MAY 10 2016

    An Entrepreneurial Approach To Funding Drug Development

    Life Science Leader, a business journal for life science executives, highlighted Oncoceutics and the company’s unique approach to funding drug development in the magazine’s May issue. An Entrepreneurial Approach to Funding Drug Development (Pay-walled)

    • APR 19 2016

    Computer to clinic: Tool developed at Weill predicts drug success

    Weill Cornell Medical College highlights the collaboration between Oncoceutics and the lab of Dr. Olivier Elemento, which used a computer algorithm developed in Dr. Elemento’s lab to predict the interaction between ONC201 and Dopamine Receptor 2, which was later validated by Oncoceutics. Computer to clinic: Tool developed at Weill predicts drug success